PT UBC Medical Indonesia Tbk (IDX:LABS)
152.00
-2.00 (-1.30%)
At close: Mar 27, 2026
IDX:LABS Market Cap
IDX:LABS has a market cap or net worth of 600.4 billion as of March 27, 2026. Its market cap has increased by 28.81% in one year.
Market Cap
600.40B
Enterprise Value
602.76B
Revenue
176.64B
Ranking
n/a
PE Ratio
64.54
Stock Price
152.00
Market Cap Chart
Since July 10, 2024, IDX:LABS's market cap has increased from 541.15B to 600.40B, an increase of 10.95%. That is a compound annual growth rate of 6.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 600.40B | 10.95% |
| Dec 30, 2025 | 541.15B | 2.24% |
| Dec 30, 2024 | 529.30B | -2.19% |
| Jul 10, 2024 | 541.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 180.31T |
| PT Kalbe Farma Tbk. | 43.50T |
| PT Siloam International Hospitals Tbk | 35.72T |
| PT Mitra Keluarga Karyasehat Tbk | 30.04T |
| PT. Penta Valent Tbk | 872.22B |
| PT Charlie Hospital Semarang Tbk | 848.00B |
| PT Itama Ranoraya Tbk | 575.99B |
| PT Diastika Biotekindo Tbk | 563.53B |